Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma

Published:2009-12 Issue:3 Volume:93 Page:458-461
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Li Bao-sheng,Zhou Tao,Wang Zhong-tang,Li Hong-sheng,Sun Hong-fu,Zhang Zhi-cheng,Lin Hai-qun,Wei Yu-mei,Gong He-yi,Huang Wei,Yi Yan,Wang Li-ying

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference19 articles.

1. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with esophageal cancer;Herskovic;N Engl J Med,1992

2. INT0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002

3. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group;Cooper;JAMA,1999

4. Late course accelerated hyperfractionation radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study;Zhao;Int J Radiat Oncol Biol Phys,2005

5. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT;Botet;Radiology,1991

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;BMC Cancer;2021-07-05

2. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;2020-08-21

3. ASO Author Reflections: Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2019-09-23

4. Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study;Annals of Surgical Oncology;2019-02-25

5. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers;Thoracic Cancer;2017-10-12